Glutamic acid decarboxylase and islet cell antibodies in healthy Estonian children

Journal of Pediatric Endocrinology and Metabolism

Volumn 12, Issue 5, 1999, Pages 667-672

  Adojaan, Bela ^a   Sabbah, Emad ^b   Vähäsalo, Paula ^b   Åkerblom, Hans K ^c   Podar, Tomas ^a   Knip, Mikael ^b,d  

^a UNIVERSITY OF TARTU   (Estonia)

^b UNIVERSITY OF OULU   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

Diabetes associated autoantibodies; Estonia; Normal population; Prediction; Prevalence

Indexed keywords

GLUTAMATE DECARBOXYLASE; PANCREAS ISLET CELL ANTIBODY;

ADOLESCENT; ANTIBODY TITER; ARTICLE; CHILD; DIABETES MELLITUS; ESTONIA; FEMALE; HUMAN; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RADIOASSAY;

EID: 0032830229     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.1999.12.5.667     Document Type: Article

References (32)

1. Thai AC, Eisenbarth G. Natural history of IDDM. Diabetes Rev 1993; 1: 1-14.
2. Knip M. Disease-associated autoimmunity and prevention of insulin-dependent diabetes mellitus. Ann Med 1997; 29: 447-451.
3. Yu L, Rewers M, Gianini R, Kawasaki E, Zhang Y, Verge C, Chase P, Klingensmith G, Erlich H, Norris J, Eisenbarth GS. Anti-islet autoantibodies usually develop sequentially rather than simultaneously. J Clin Endocrinol Metab 1996; 81: 4264-4267.
4. Srikanta S, Ganda OP, Rabizadeh A, Soeldner JS, Eisenbarth GS. First degree relatives of patients with type 1 diabetes mellitus: islet cell antibodies and abnormal insulin secretion. N Engl J Med 1985; 313: 461-464.
5. Tarn AC, Thomas JM, Dean BM, Ingram D, Schwartz G, Bottazzo GF, Gale EA. Predicting insulin-dependent diabetes. Lancet 1988; i: 845-850.
6. Bonifacio E, Bingley PJ, Shattock M, Dean BM, Dunger D, Gale EAM, Bottazzo GF. Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet 1990; i: 147-149.
7. Riley WJ, Maclaren NK, Krischer J, Spillar RP, Silverstein JH, Schatz, DA, Schwartz S, Malone J, Shah S, Vadheim C, Rotter JI. A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N Engl J Med 1990; 323: 1167-1172.
8. Karjalainen J, Vähäsalo P, Knip M, Tuomilehto-Wolf E, Virtala E, Akerblom HK, the Childhood Diabetes in Finland Study Group. Islet cell autoimmunity and progression to IDDM in genetically high and low risk siblings of diabetic children. Eur J Clin Invest 1996; 26: 640-649.
9. Palmer JP, Asplin CM, Clemons P, Lyen K, Tatpati O, Raghu PK, Paquette TL. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 1983; 222: 1337-1339.
10. Baekkeskov S, Aanstoot H-J, Christgau S, Reetz A, Solimena M, Cascalho M, Folli F, Richter-Olesen H, DeCamilli P. Identification of the 64 K autoantigen in insulin-dependent diabetes as the GABA-synthesising enzyme glutamic acid decarboxylase. Nature 1990; 347: 151-156.
11. Lan MS, Lu J, Goto Y, Notkins AL. Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2 from human insulinoma. DNA Cell Biol 1994; 13: 505-514.
12. Veijola R, Reijonen H, Vähäsalo P, Sabbah E, Kulmala P, Ilonen J, Åkerblom HK, Knip M, the Childhood Diabetes in Finland Study Group. HLA DQB1 defined genetic susceptibility, beta-cell autoimmunity and metabolic characteristics in familial and non-familial insulin-dependent diabetes mellitus. J Clin Invest 1996; 98: 2489-2495.
13. Knip M, Åkerblom HK. IDDM prevention trials in progress - a critical assessment. J Pediatr Endocrinol Metab 1998; 11 (Suppl 2): 371-377.
14. Bingley PJ, Bonifacio E, Shattock M, Gillmor HA, Sawtell PA, Dunger DB, Scott RD, Bottazzo GF, Gale EA. Can islet cell antibodies predict IDDM in the general population? Diabetes Care 1993; 16: 45-50.
15. Schatz D, Krischer J, Horne G, Riley W, Spillar R, Silverstein J, Winter W, Muir A, Derovanesian D, Shah S, Malone J, Maclaren N. Islet cell antibodies predict insulin-dependent diabetes in United States school age children as powerfully as in unaffected relatives. J Clin Invest 1994; 93: 2403-2407.
16. Tuomilehto J, Podar T, Reunanen A, Kalits I, Lounamaa R, Tuomilehto-Wolf E, Adojaan B, Neff B, LaPorte RE. Comparison of incidence of IDDM in childhood between Estonia and Finland, 1980-1988. Diabetes Care 1991; 14: 982-988.
17. Petersen JS, Hejnaes KR, Moody A, Karlsen AE, Marshall MO, Høier-Madsen M, Boel E, Michelsen BK, Dyrberg T. Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes 1994; 43: 459-467.
18. Sabbah E, Kulmala P, Veijola R, Vähäsalo P, Karjalainen K, Tuomilehto-Wolf E, Åkerblom HK, Knip M, the Childhood Diabetes in Finland Study Group. GAD65 antibodies in relation to other autoantibodies and genetic risk markers in children with newly diagnosed IDDM. J Clin Endocrinol Metab 1996; 81: 2455-2458.
19. Verge CF, Stenger D, Bonifacio E, Colman PG, Pilcher C, Bingley PJ, Eisenbarth GS, participating laboratories. Combined use of autoantibodies (IA-2 ab, GAD ab, IAA, ICA) in type 1 diabetes: Combinatorial islet autoantibody workshop. Diabetes 1998; 47: 1857-1866.
20. Bottazzo GF, Florin-Christensen A, Doniach D. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 1974; ii: 1279-1282.
21. Podar T, Tuomilehto-Wolf E, Tuomilehto J, LaPorte RE, Adojaan B. Insulin-dependent diabetes mellitus in native Estonians and immigrants to Estonia. Am J Epidemiol 1992: 135: 1231-1236.
22. Bruining GJ, Molenaar JL, Grobbee DE, Hofman A, Scheffer GJ, Braining HA, de Bruyn AM, Valkenburg HA. Ten-year follow-up study of islet cell antibodies and childhood diabetes. Lancet 1989; i: 1100-1103.
23. Karjalainen J. Islet cell antibodies as predictive markers for IDDM in children with high background incidence of disease. Diabetes 1990; 39: 1144-1150.
24. Adojaan B, Knip M, Karjalainen J, Kalits I, Åkerblom HK. Relation between incidence of childhood IDDM and frequency of ICA positivity in unaffected children in the general population. Diabetes Care 1996; 19: 1452-1454.
25. Aanstoot HJ, Petersen JS, Batstra MR, de Man S, Scholtens A, Jensen E, Molenaar JL, de Bruijn T, Grobbee D, Bruining GJ, Dyrberg T. Low frequency of antibodies to glutamic acid decarboxylase in the general population. Diabetologia 1995; 38 (Suppl 1): A54 (Abst).
26. Leech NJ, McCulloch DK, Rowe RE, Palmer JP, Hagopian WA. The role of GAD65Ab in the prediction of IDDM in the general population and its relationship to other susceptibility markers. Autoimmunity 1995; 21: 63-64 (Abst).
27. Bingley PJ, Bonifacio E, Williams AJK, Genovese S, Bottazzo GF, Gale EAM. Prediction of IDDM in the general population. Strategies based on combinations of autoantibody markers. Diabetes 1997; 46: 1701-1710.
28. Hyöty H, Hiltunen M, Knip M, Laakkonen M, Vähäsalo P, Karjalainen J, Roivainen M, Leinikki P, Hovi T, Åkerblom HK, the Childhood Diabetes in Finland Study Group. A prospective study of the role of Coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Diabetes 1995; 44: 652-657.
29. Hiltunen M, Hyöty H, Knip M, Ilonen J, Reijonen H, Vähäsalo P, Roivainen M, Leinikki P, Hovi H, Åkerblom HK, the Childhood Diabetes in Finland (DiMe) Study Group. ICA seroconversion in children is temporally associated with enterovirus infections. J Infect Dis 1997; 175: 554-560.
30. Bingley PJ, Christie MR, Bonifacio E, Bonfanti R, Schattock M, Fonte MT, Bottazzo GF, Gale EA. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 1994; 43: 1304-1310.
31. Verge CF, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Jackson RA, Chase HP, Eisenbarth GS. Prediction of type 1 diabetes in first-degree relatives using a combination of insulin, GAD and ICA512bdc/IA-2 antibodies. Diabetes 1996; 45: 926-933.
32. Kulmala P, Savola K, Petersen JS, Vähäsalo P, Karjalainen J, Löppönen T, Dyrberg T, Åkerblom HK, Knip M, the Childhood Diabetes in Finland Study Group. Prediction of insulin-dependent diabetes mellitus in siblings of children with IDDM. A population-based study. J Clin Invest 1998; 101: 327-336.